> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA ‘Emergency Use’ Granted to Nanobiosym Zika Test
- URL: https://www.fdaweb.com/fda-emergency-use-granted-to-nanobiosym-zika-test/
- Published: 2017-04-11T12:00:00.000Z
- Updated: 2026-09-14T22:17:00.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5138429

FDA has issued Nanobiosym Diagnostics an emergency use authorization for the Gene-RADAR Zika Virus Test. The device is authorized for the qualitative detection of RNA from Zika virus in human serum from individuals meeting Centers for Disease Control and Prevention Zika virus clinical or epidemiological criteria. “Currently, Zika virus RNA has been detected in serum up to 13 days post-symptom onset in non-pregnant patients, up to 62 days post-symptom onset in pregnant patients and up to 53 days after the last known possible exposure in an asymptomatic pregnant woman.” according to the company.